Beyond Ozempic: The GLP-1 Boom
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
Beyond Ozempic: The GLP-1 Boom
-
Narrated by:
-
By:
About this listen
Ozempic. Wegovy. Mounjaro. Zepbound. You’ve probably heard the name of one of these drugs in the past few years—maybe you’ve even thought about taking them. Every day, more Americans are taking these drugs known as GLP-1s, either for chronic conditions like diabetes or, increasingly, for weight loss. So do these drugs deliver on the promise of easy weight loss? And are they right for everyone? This episode, we talk with Mayo Clinic dietitian and host of Mayo Clinic On Nutrition Tara Schmidt about the drugs that have taken weight loss culture by storm.
Find us online at Mayo Clinic Press for more health and wellness articles, podcasts and books.
Do you have feedback, questions or topic suggestions? Email us at mcppodcasts@mayo.edu.
Advertising Inquiries: https://redcircle.com/brands
Privacy & Opt-Out: https://redcircle.com/privacy
adbl_web_global_use_to_activate_T1_webcro805_stickypopup
No reviews yet